Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhageBRADY, Kenneth M; EASLEY, R. Blaine; TOBIAS, Toseph D et al.Paediatric anaesthesia (Paris). 2006, Vol 16, Num 10, pp 1042-1046, issn 1155-5645, 5 p.Article

Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgeryHYLLNER, Monica; HOULTZ, Erik; JEPPSSON, Anders et al.European journal of cardio-thoracic surgery. 2005, Vol 28, Num 2, pp 254-258, issn 1010-7940, 5 p.Article

Prolonged Prothrombin Time After Recombinant Activated Factor VII Therapy in Critically Bleeding Trauma Patients Is Associated With Adverse OutcomesMCMULLIN, Neil R; WADE, Charles E; TORTELLA, Bartholomew J et al.The Journal of trauma, injury, infection, and critical care. 2010, Vol 69, Num 1, pp 60-69, issn 1079-6061, 10 p.Article

Prohemostatic Interventions in Obstetric HemorrhageBONNET, Marie-Pierre; BASSO, Olga.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 3, pp 259-264, issn 0094-6176, 6 p.Article

The use of recombinant factor VIIa in liver diseasesFRANCHINI, Massimo; MONTAGNANA, Martina; TARGHER, Giovanni et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 5, pp 341-348, issn 0957-5235, 8 p.Article

The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infantCETIN, Hasan; YALIZ, Mehmet; AKISU, Mete et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 3, pp 213-216, issn 0957-5235, 4 p.Article

Activity of recombinant factor VIIa under different conditions in vitro : effect of temperature, pH, and haemodilutionBLADBJERG, Else-Marie; JESPERSEN, Jørgen.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 5, pp 369-374, issn 0957-5235, 6 p.Article

Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypassDIDOMENICO, Robert J; MASSAD, Malek C; KPODONU, Jacques et al.Chest. 2005, Vol 127, Num 5, pp 1828-1835, issn 0012-3692, 8 p.Article

The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock SyndromeCHUANSUMRIT, Ampaiwan; TANGNARARATCHAKIT, Kanchana; LEKTAKUL, Yujinda et al.Blood coagulation & fibrinolysis. 2004, Vol 15, Num 4, pp 335-342, issn 0957-5235, 8 p.Article

Recombinant activated factor VII for refractory bleeding after cardiac surgery : A retrospective analysis of safety and efficacyVON HEYMANN, Christian; REDLICH, Uwe; WERNECKE, Klaus-Dieter et al.Critical care medicine. 2005, Vol 33, Num 10, pp 2241-2246, issn 0090-3493, 6 p.Article

The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiencyCANATAN, Duran; EREN, Erdal; OZGÜNER, I. Faruk et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 4, pp 375-376, issn 0957-5235, 2 p.Article

The use of recombinant-activated factor VII in von willebrand disease : a case seriesVON DEPKA, Mario; HASSAN, Murtada; BLATNY, Jan et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 4, pp 311-316, issn 0957-5235, 6 p.Article

A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjectsFRIDBERG, Marianne J; HEDNER, Ulla; ROBERTS, Harold R et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 4, pp 259-266, issn 0957-5235, 8 p.Article

Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombastheniaCHUANSUMRIT, Ampaiwan; SUWANNURAKS, Monthon; SRI-UDOMPORN, Nantana et al.Blood coagulation & fibrinolysis. 2003, Vol 14, Num 2, pp 187-190, issn 0957-5235, 4 p.Article

A review of the off-label use of recombinant activated factor VII in a developing country tertiary care centerEL ACCAOUI, Ramzi; ISMA'EEL, Hussain; BOU KHALIL, Pierre et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 8, pp 647-650, issn 0957-5235, 4 p.Article

Administration of recombinant factor VIIa decreases blood loss after blunt trauma in noncoagulopathic pigsHOWES, Daniel William; STRATFORD, Andrew; STIRLING, Michael et al.The Journal of trauma, injury, infection, and critical care. 2007, Vol 62, Num 2, pp 311-315, issn 1079-6061, 5 p.Article

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulationTANAKA, Kenichi A; SZLAM, Fania; DICKNEITE, Gerhard et al.Thrombosis research. 2008, Vol 122, Num 1, pp 117-123, issn 0049-3848, 7 p.Article

Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients : A retrospective comparative study. CommentaryROITBERG, Ben; EMECHEBE-KENNEDY, Obinna; AMIN-HANJANI, Sepideh et al.Neurosurgery. 2005, Vol 57, Num 5, pp 832-836, issn 0148-396X, 5 p.Article

Effectiveness of Recombinant Activated Factor VII (rFVII a) for Controlling Intractable Postpartum Bleeding : Report of Two Cases and Literature ReviewJIRAPINYO, Mayuree; MANONAI, Jittima; HERABUTYA, Yongyoth et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 5, pp 977-981, issn 0125-2208, 5 p.Article

Treatment of Warfarin-Related Intracranial Hemorrhage: A Comparison of Prothrombin Complex Concentrate and Recombinant Activated Factor VIIPINNER, Nathan A; HURDLE, April C; OLIPHANT, Carrie et al.World neurosurgery (Print). 2010, Vol 74, Num 6, pp 631-635, issn 1878-8750, 5 p.Article

The use of recombinant activated factor VII in congenital and acquired von Willebrand diseaseFRANCHINI, Massimo; VENERI, Dino; LIPPI, Giuseppe et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 8, pp 615-619, issn 0957-5235, 5 p.Article

Successful use of recombinant activated factor vii in the treatment of vitreous haemorrhage : a report of seven casesALAMERI, All; NAGHAM SALMAN BAKER.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 8, pp 573-578, issn 0957-5235, 6 p.Article

In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liverSEESTED, T; APPA, R. S; CHRISTENSEN, E. I et al.Thrombosis research. 2011, Vol 127, Num 4, pp 356-362, issn 0049-3848, 7 p.Article

Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorderEL KINGE, Abdul Rahman D; MAHFOUZ, Rami A; SHAMSEDDINE, Ali I et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 6, pp 577-579, issn 0957-5235, 3 p.Article

Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder : a case reportINAGAKI, Minoru; MORI, Tetsuya; TSUNEMATSU, Yukiko et al.Blood coagulation & fibrinolysis. 2006, Vol 17, Num 4, pp 317-322, issn 0957-5235, 6 p.Article